Mild Cognitive Impairment Associated with Obstructive Sleep Apnoea: A Pilot Study on Oxygen-Related Plasma Biomarkers...

Obstructive sleep apnoea syndrome (OSAS) is a breathing disorder frequently associated with mild cognitive impairment (MCI), a potential prodromal stage of Alzheimer's disease (AD). However, the mechanisms underlying MCI in OSAS remain unclear, making the identification of early biomarkers crucial. This pilot study investigates biochemical parameters related to oxygen disturbance and AD in OSAS patients with and without MCI (OSAS + MCI and OSAS-MCI, respectively) and explores their interplay through a network-based analysis. A total of 45 subjects (30 OSAS patients; 15 healthy controls) were enrolled, undergoing clinical assessment, polygraphy, and blood sampling. Compared to controls, OSAS patients exhibited increased apnoea-hypopnea index, oxygen desaturation index, and the percentage of cumulative time with oxygen saturation below 90% during total sleep time (T90). Notably, in the entire OSAS cohort, T90 positively correlated with HIF-1α levels, which were higher than controls, although not significantly. Interestingly, both T90 and HIF-1α were elevated in OSAS + MCI patients compared to OSAS-MCI, confirming a positive correlation between their levels. Regarding AD-related biomarkers, t-Tau and p-Tau₁₈₁ levels were elevated in OSAS + MCI. AUROC analysis demonstrated that HIF-1α and t-Tau had fair discriminative ability, whereas p-Tau₁₈₁ showed good differentiation between OSAS + MCI and OSAS-MCI. Finally, a network-based analysis suggested HIF-1α as possible candidate player in disease pathways, potentially interacting with Tau phosphorylation via GSK-3β. These findings recommend HIF-1α, t-Tau, and p-Tau₁₈₁ as possible peripheral candidates for early MCI detection in OSAS, pointing out their possible involvement in the pathogenesis of cognitive impairment in OSAS pathology.